Central Pacific Bank - Trust Division’s ARK Genomic Revolution ETF ARKG Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84	Buy	+2	New	+$64	﹤0.01%	878

Other funds holding ARKG

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Central Pacific Bank - Trust Division's ARKG Position: Q2 2026 in Review

Central Pacific Bank - Trust Division opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 2 shares worth $84. The stake represents ﹤0.01% of the portfolio and ranks #878 among its holdings.

169 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Central Pacific Bank - Trust Division held 2 shares of ARK Genomic Revolution ETF worth $84 as of Q2 2026.
ARK Genomic Revolution ETF was a new Central Pacific Bank - Trust Division position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #878 holding.
169 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.